Dr. Brij. M. Gandhi, M.Sc., Ph.D. is presently CEO and founder of Neo BioMed Services (www.neobiomed.com), providing services and consultancy in health areas and regulatory issues related to biopharmaceuticals, pharmaceuticals, including stem cell and regenerative medicine. Dr. Gandhi had his Masters in Biochemistry from PAU and Ph.D. in Experimental Medicine from the University of Bergan, Norway. He was trained at the Massachusetts Institute of Technology, USA; London School of Hygiene and Tropical Medicine, London; National Institutes of Health, Maryland, USA; Hvidovre Hospital, Copenhagen and University of Bergan, Norway. Dr. Gandhi retired in 2006 as Adviser to the Government of India, Ministry of Science and Technology, Department of Biotechnology, managing promotion and policy related issues in biotechnology related to international collaborations, medical biotechnology, infrastructure development, animals and aquaculture biotechnology. Prior to that he was Research Scientist at AIIMS working on immunology of parasitic, bacterial and viral infections including amoebic diseases; hepatitis; liver diseases, IVD, food and nutritional health issues. Dr. Gandhi continues to serve as Advisor / Director to a number of institutions/pharma and biopharma industries with an experience of about 50 years of active service, as research scientist, science manager, adviser/consultant and over 155 publications.